Data / Drug companies / Ax Pharmaceutical Corp
Ax Pharmaceutical Corp: 123 products in the FDA NDC directory, labeler code 73377
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Ax Pharmaceutical Corp (labeler code 73377) lists 123 products in the FDA National Drug Code Directory. By type: 123 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on October 28, 2026.
The request: Watch Ax Pharmaceutical Corp (FDA labeler code 73377): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 73377
- Products in commercial distribution
- 123
- Packages
- 404
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 3, Schedule IV 1, Schedule V 1
- Started marketing in the last 12 months
- 21
- Products with a marketing end date set
- 9
- Earliest marketing start
- January 24, 2020
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients for compounding | 121 | 98.4% |
| Bulk ingredients | 2 | 1.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 123 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 121 | 98.4% |
| Suspension | 1 | 0.8% |
| Oil | 1 | 0.8% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Dapoxetine hcl | 73377-374 | Powder | Bulk ingredients for compounding | October 28, 2026 |
| Atorvastatin calcium trihydrate | 73377-372 | Powder | Bulk ingredients for compounding | October 2, 2026 |
| Testosterone cypionate | 73377-370 | Powder | Bulk ingredients for compounding | September 3, 2026 |
| Testosterone undecanoate | 73377-369 | Powder | Bulk ingredients for compounding | September 3, 2026 |
| Betahistine dihydrochloride | 73377-368 | Powder | Bulk ingredients for compounding | August 13, 2026 |
| Zinc pyrithione | 73377-364 | Suspension | Bulk ingredients for compounding | July 30, 2026 |
| Phenoxybenzamine hcl | 73377-363 | Powder | Bulk ingredients for compounding | July 20, 2026 |
| Sirolimus | 73377-360 | Powder | Bulk ingredients for compounding | July 3, 2026 |
| Paroxetine hydrochloride hemihydrate | 73377-359 | Powder | Bulk ingredients for compounding | June 26, 2026 |
| Bupropion hcl | 73377-358 | Powder | Bulk ingredients for compounding | June 17, 2026 |
| Orlistat | 73377-356 | Powder | Bulk ingredients for compounding | May 27, 2026 |
| Levocarnitine | 73377-355 | Powder | Bulk ingredients for compounding | May 27, 2026 |
| Alprostadil | 73377-354 | Powder | Bulk ingredients for compounding | May 22, 2026 |
| Podophyllum resin | 73377-348 | Powder | Bulk ingredients for compounding | March 27, 2026 |
| Celecoxib | 73377-345 | Powder | Bulk ingredients for compounding | February 6, 2026 |
| Efinaconazole | 73377-344 | Powder | Bulk ingredients for compounding | February 4, 2026 |
| Leucovorin calcium | 73377-342 | Powder | Bulk ingredients for compounding | January 8, 2026 |
| Telmisartan | 73377-340 | Powder | Bulk ingredients for compounding | December 29, 2025 |
| Nicotinamide adenine dinucleotide | 73377-339 | Powder | Bulk ingredients for compounding | December 3, 2025 |
| Tadalafil | 73377-338 | Powder | Bulk ingredients | November 20, 2025 |
| Sodium phenylbutyrate | 73377-337 | Powder | Bulk ingredients for compounding | November 11, 2025 |
| Olopatadine hci | 73377-336 | Powder | Bulk ingredients for compounding | October 28, 2025 |
| Mycophenolate mofetil | 73377-335 | Powder | Bulk ingredients for compounding | October 22, 2025 |
| Mometasone furoate | 73377-334 | Powder | Bulk ingredients for compounding | October 9, 2025 |
| Albendazole | 73377-333 | Powder | Bulk ingredients for compounding | September 3, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.